63 related articles for article (PubMed ID: 21633787)
1. Polymorphisms in the promoter region of the CASP8 gene are not associated with non-Hodgkin's lymphoma in Chinese patients.
Xiao MS; Zhang DF; Zeng Y; Cheng YF; Yao YG
Ann Hematol; 2011 Oct; 90(10):1137-44. PubMed ID: 21633787
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of the CASP8 gene promoter may not be associated with colorectal cancer in Han Chinese from southwest China.
Xiao MS; Chang L; Li WL; Du YS; Pan Y; Zhang DF; Wen Y; Luo J; Li XY; Yao YG
PLoS One; 2013; 8(7):e67577. PubMed ID: 23844036
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
Monne M; Piras G; Palmas A; Arru L; Murineddu M; Latte G; Noli A; Gabbas A
Am J Hematol; 2004 May; 76(1):14-8. PubMed ID: 15114591
[TBL] [Abstract][Full Text] [Related]
4. Tumor necrosis factor promoter gene polymorphism associated with increased susceptibility to non-Hodgkin's lymphomas.
Bel Hadj Jrad B; Chatti A; Laatiri A; Ahmed SB; Romdhane A; Ajimi S; Chouchane L
Eur J Haematol; 2007 Feb; 78(2):117-22. PubMed ID: 17087739
[TBL] [Abstract][Full Text] [Related]
5. Methylation of promoter region in p27 gene plays a role in the development of lymphoid malignancies.
Nakatsuka S; Liu A; Yao M; Takakuwa T; Tomita Y; Hoshida Y; Nishiu M; Aozasa K
Int J Oncol; 2003 Mar; 22(3):561-8. PubMed ID: 12579309
[TBL] [Abstract][Full Text] [Related]
6. Common gene polymorphisms in the metabolic folate and methylation pathway and the risk of acute lymphoblastic leukemia and non-Hodgkin's lymphoma in adults.
Gemmati D; Ongaro A; Scapoli GL; Della Porta M; Tognazzo S; Serino ML; Di Bona E; Rodeghiero F; Gilli G; Reverberi R; Caruso A; Pasello M; Pellati A; De Mattei M
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):787-94. PubMed ID: 15159311
[TBL] [Abstract][Full Text] [Related]
7. [The role of genetic polymorphisms within tumor necrosis factor promoter gene in non-Hodgkin's lymphomas].
Juszczyński P; Kalinka E; Woszczek G; Borowiec M; Robak T; Kowalski ML; Biliński P; Coiffiers B; Salles G; Warzocha K
Przegl Lek; 2005; 62(12):1417-21. PubMed ID: 16786763
[TBL] [Abstract][Full Text] [Related]
8. [Epidemiology studies on associations between gene polymorphisms and non-Hodgkin's lymphoma].
Ye XB; Fu H
Wei Sheng Yan Jiu; 2006 May; 35(3):384-6. PubMed ID: 16921776
[TBL] [Abstract][Full Text] [Related]
9. Effect of interleukin-10 gene polymorphisms on clinical outcome of patients with aggressive non-Hodgkin's lymphoma: an exploratory study.
Kube D; Hua TD; von Bonin F; Schoof N; Zeynalova S; Klöss M; Gocht D; Potthoff B; Tzvetkov M; Brockmöller J; Löffler M; Pfreundschuh M; Trümper L
Clin Cancer Res; 2008 Jun; 14(12):3777-84. PubMed ID: 18559596
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas.
Soucek P; Sarmanová J; Kristensen VN; Apltauerová M; Gut I
Int Arch Occup Environ Health; 2002 Oct; 75 Suppl():S86-92. PubMed ID: 12397416
[TBL] [Abstract][Full Text] [Related]
11. Functional implication of TRAIL -716 C/T promoter polymorphism on its in vitro and in vivo expression and the susceptibility to sporadic breast tumor.
Pal R; Gochhait S; Chattopadhyay S; Gupta P; Prakash N; Agarwal G; Chaturvedi A; Husain N; Husain SA; Bamezai RN
Breast Cancer Res Treat; 2011 Apr; 126(2):333-43. PubMed ID: 20443055
[TBL] [Abstract][Full Text] [Related]
12. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer.
Zhang X; Miao X; Tan W; Ning B; Liu Z; Hong Y; Song W; Guo Y; Zhang X; Shen Y; Qiang B; Kadlubar FF; Lin D
Gastroenterology; 2005 Aug; 129(2):565-76. PubMed ID: 16083713
[TBL] [Abstract][Full Text] [Related]
13. Codeletion of CDKN2 and MTAP genes in a subset of non-Hodgkin's lymphoma may be associated with histologic transformation from low-grade to diffuse large-cell lymphoma.
Dreyling MH; Roulston D; Bohlander SK; Vardiman J; Olopade OI
Genes Chromosomes Cancer; 1998 May; 22(1):72-8. PubMed ID: 9591637
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel epigenetic markers in non-Hodgkin's lymphoma.
Shi H; Guo J; Duff DJ; Rahmatpanah F; Chitima-Matsiga R; Al-Kuhlani M; Taylor KH; Sjahputera O; Andreski M; Wooldridge JE; Caldwell CW
Carcinogenesis; 2007 Jan; 28(1):60-70. PubMed ID: 16774933
[TBL] [Abstract][Full Text] [Related]
15. Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case-control analysis.
Li C; Wu W; Liu J; Qian L; Li A; Yang K; Wei Q; Zhou J; Zhang Z
Pharmacogenet Genomics; 2006 Apr; 16(4):245-51. PubMed ID: 16538171
[TBL] [Abstract][Full Text] [Related]
16. [The role of HLA DRB1 genetic polymorphisms in non-Hodgkin's lymphomas].
Kalinka E; Juszczyński P; Woszczek G; Borowiec M; Robak T; Kowalski ML; Biliński P; Coiffier B; Salles G; Warzocha K
Przegl Lek; 2005; 62(12):1422-6. PubMed ID: 16786764
[TBL] [Abstract][Full Text] [Related]
17. Association of caspase 8 promoter variants and haplotypes with the risk of breast cancer and its molecular profile in an Iranian population: A case-control study.
Bagherabad MB; Afzaljavan F; Vahednia E; Rivandi M; Vakili F; Sadr SSH; Shandiz FH; Pasdar A
J Cell Biochem; 2019 Oct; 120(10):16435-16444. PubMed ID: 31257627
[TBL] [Abstract][Full Text] [Related]
18. TGF-beta1 gene polymorphisms influence the course of the disease in non-Hodgkin's lymphoma patients.
Mazur G; Bogunia-Kubik K; Wrobel T; Kuliczkowski K; Lange A
Cytokine; 2006 Feb; 33(3):145-9. PubMed ID: 16524740
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor and lymphotoxin alfa genetic polymorphisms and outcome in pediatric patients with non-Hodgkin's lymphoma: results from Berlin-Frankfurt-Münster Trial NHL-BFM 95.
Seidemann K; Zimmermann M; Book M; Meyer U; Burkhardt B; Welte K; Reiter A; Stanulla M
J Clin Oncol; 2005 Nov; 23(33):8414-21. PubMed ID: 16293872
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of methylenetetrahydrofolate reductase and promoter methylation of MGMT and FHIT genes in diffuse large B cell lymphoma risk in Middle East.
Siraj AK; Ibrahim M; Al-Rasheed M; Bu R; Bavi P; Jehan Z; Abubaker J; Murad W; Al-Dayel F; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Ann Hematol; 2007 Dec; 86(12):887-95. PubMed ID: 17712558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
